ICCC — IMMUCELL CORP /DE/
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-18 | te Boekhorst Paul Francis Olivier President and CEO | Open-market purchase | 8.0K | 9.49 | 76.0K |
| 2026-03-20 | BRIGHAM MICHAEL F Director | Option exercise | 25.0K | 5.84 | 146.0K |
| 2026-03-20 | BRIGHAM MICHAEL F Director | Shares withheld for tax | 24.1K | 6.07 | 146.0K |
| 2025-12-04 | te Boekhorst Paul Francis Olivier President and CEO | Open-market purchase | 2.4K | 5.50 | 13.4K |
| 2025-12-03 | te Boekhorst Paul Francis Olivier President and CEO | Open-market purchase | 3.6K | 5.05 | 18.2K |
| 2025-12-03 | te Boekhorst Paul Francis Olivier President and CEO | Open-market purchase | 3.5K | 5.04 | 17.7K |
| 2025-12-03 | te Boekhorst Paul Francis Olivier President and CEO | Open-market purchase | 2.6K | 5.00 | 12.8K |
| 2025-12-02 | te Boekhorst Paul Francis Olivier President and CEO | Open-market purchase | 3.7K | 4.87 | 18.1K |
| 2025-11-25 | Tomsche David Scott Director | Open-market purchase | 1.6K | 4.77 | 7.8K |
| 2025-11-25 | Tomsche David Scott Director | Open-market purchase | 1.6K | 4.76 | 7.8K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | 260.3K |
| MORGAN STANLEY | 1.4M | 221.7K |
| RENAISSANCE TECHNOLOGIES LLC | 960.8K | 151.8K |
| Cresset Asset Management, LLC | 856.2K | 135.3K |
| Bleichroeder LP | 643.1K | 101.6K |
| GEODE CAPITAL MANAGEMENT, LLC | 416.4K | 65.8K |
| DIMENSIONAL FUND ADVISORS LP | 354.7K | 56.0K |
| Steadtrust LLC | 344.2K | 54.4K |
| VANGUARD FIDUCIARY TRUST CO | 270.1K | 42.7K |
| Mesirow Financial Investment Management, Inc. | 268.9K | 42.5K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-13 | 2026-08-13 | on EDGAR ↗ |
| 8-K | 2026-07-09 | 2026-07-09 | on EDGAR ↗ |
| 4 | 2026-06-22 | 2026-06-18 | on EDGAR ↗ |
| 8-K | 2026-06-17 | 2026-06-11 | on EDGAR ↗ |
| 8-K | 2026-06-10 | 2026-06-04 | on EDGAR ↗ |
| 8-K | 2026-05-14 | 2026-05-14 | on EDGAR ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- ImmuCell (ICCC) Q2 2026 Earnings Call Transcript · 2026-08-20
- ImmuCell outlines ~$4.5M liquids expansion, targeting more than 3x capacity by end of 2027 · 2026-08-14
- Immucell Corp /de/ (ICCC) filed form 8-K · 2026-08-13 · SEC EDGAR
Ask the AI about ICCC
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →